MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection
- PMID: 33531391
- PMCID: PMC7858076
- DOI: 10.1128/mBio.03447-20
MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection
Figures
Comment in
-
Reply to Marakasova and Baranova, "MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection".mBio. 2021 Feb 2;12(1):e03682-20. doi: 10.1128/mBio.03682-20. mBio. 2021. PMID: 33531392 Free PMC article. No abstract available.
Comment on
-
Analysis of Measles-Mumps-Rubella (MMR) Titers of Recovered COVID-19 Patients.mBio. 2020 Nov 20;11(6):e02628-20. doi: 10.1128/mBio.02628-20. mBio. 2020. PMID: 33219096 Free PMC article.
References
-
- Grifoni A, Weiskopf D, Ramirez SI, Mateus J, Dan JM, Moderbacher CR, Rawlings SA, Sutherland A, Premkumar L, Jadi RS, Marrama D, de Silva AM, Frazier A, Carlin AF, Greenbaum JA, Peters B, Krammer F, Smith DM, Crotty S, Sette A. 2020. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 181:1489–1501.e15. doi: 10.1016/j.cell.2020.05.015. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
